LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 95 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.9%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,641,784 | +47628.7% | 761,321 | +0.8% | 0.00% | -50.0% |
| Q3 2022 | $5,535 | +19.9% | 755,105 | +6.7% | 0.01% | +20.0% |
| Q2 2022 | $4,615 | +16.5% | 707,665 | -9.8% | 0.01% | +66.7% |
| Q1 2022 | $3,963 | -29.2% | 784,741 | +8.5% | 0.00% | 0.0% |
| Q4 2021 | $5,599 | -11.5% | 723,370 | +69.2% | 0.00% | 0.0% |
| Q3 2021 | $6,327 | +50.5% | 427,483 | +65.2% | 0.00% | +50.0% |
| Q2 2021 | $4,204 | – | 258,823 | – | 0.00% | – |
Download | ||||||